Eagle’s Eye View: What is the role of inflammation as a predictor of coronary risk?
In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.
- Kim Eagle, MD, MACC keaglemd
Keywords: EaglesEyeView, Atrial Fibrillation, Lung Diseases, Interstitial, Lung Neoplasms, Cholesterol, LDL, C-Reactive Protein, Inflammation, Antihypertensive Agents, Blood Pressure, Denervation
< Back to Listings